이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Create Medic 관리

관리 기준 확인 2/4

Create Medic's CEO는 Masahiro Sato, Jan2024 에 임명되었습니다 의 임기는 1년 미만입니다. 는 ¥ 12.83M 가치에 해당하는 회사 주식의 0.15% 직접 소유합니다. 12.83M. 경영진과 이사회의 평균 재임 기간은 각각 3.7 년과 6.3 년입니다.

주요 정보

Masahiro Sato

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	less than a year
CEO 소유권	0.1%
경영진 평균 재임 기간	3.7yrs
이사회 평균 재임 기간	6.3yrs

최근 관리 업데이트

Recent updates

CEO

Masahiro Sato (64 yo)

less than a year

테뉴어

Mr. Masahiro Sato has been the Chairman at Create Medic Co. Ltd. since March 2023 and Representative Director since March 2013 and serves as President since 2024. He had been the President of Create Medic...

리더십 팀

이름	위치	테뉴어	보상	소유권
Masahiro Sato	President	less than a year	데이터 없음	0.15% ¥ 12.3m
Osamu Imazawa	GM of Administration Headquarters & Director	4.3yrs	데이터 없음	0.034% ¥ 2.8m
Shinichi Endo	Director of Market Development	3.2yrs	데이터 없음	0.12% ¥ 10.4m
Katsuya Akimoto	GM of Sales Headquarters	no data	데이터 없음	0.14% ¥ 11.4m
Yozo Akaoka	SMEO, GM of Development Division and Consolidated Management Headquarters & Director	22.3yrs	데이터 없음	0.16% ¥ 13.2m

3.7yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 관리: 5187 의 관리팀은 경험 ( 3.7 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Masahiro Sato	President	11.3yrs	데이터 없음	0.15% ¥ 12.3m
Osamu Imazawa	GM of Administration Headquarters & Director	1.3yrs	데이터 없음	0.034% ¥ 2.8m
Shinichi Endo	Director of Market Development	13.3yrs	데이터 없음	0.12% ¥ 10.4m
Katsuya Akimoto	GM of Sales Headquarters	6.3yrs	데이터 없음	0.14% ¥ 11.4m
Yozo Akaoka	SMEO, GM of Development Division and Consolidated Management Headquarters & Director	13.3yrs	데이터 없음	0.16% ¥ 13.2m
Atsushi Hashii	Director	10.3yrs	데이터 없음	0.14% ¥ 11.4m
Kazutoshi Isogai	Independent Outside Director	4.3yrs	데이터 없음	0.034% ¥ 2.8m
Ryoichi Higurashi	Independent Outside Director	4.3yrs	데이터 없음	데이터 없음
Atsuko Kudo	Independent Director	less than a year	데이터 없음	데이터 없음

6.3yrs

평균 재임 기간

63.5yo

평균 연령

경험이 풍부한 이사회: 5187 의 이사회는 경험(평균 재직 기간 6.3 년)으로 간주됩니다.

Create Medic 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Create Medic Co., Ltd., Annual General Meeting, Mar 30, 2023

Less than half of directors are independent

Less than half of directors are independent

Create Medic Co., Ltd., Annual General Meeting, Mar 30, 2021

Recent updates

Upcoming dividend of JP¥19.00 per share

Create Medic Co., Ltd. to Report Q2, 2024 Results on Aug 05, 2024

First quarter 2024 earnings released: EPS: JP¥6.51 (vs JP¥14.18 in 1Q 2023)

Final dividend of JP¥19.00 announced

Create Medic Co., Ltd. to Report Q1, 2024 Results on May 07, 2024

Full year 2023 earnings released: EPS: JP¥16.92 (vs JP¥50.56 in FY 2022)

Create Medic Co., Ltd. (TSE:5187) announces an Equity Buyback for 600,000 shares, representing 6.59% for ¥500 million.

Create Medic Co., Ltd. to Report Fiscal Year 2023 Results on Feb 14, 2024

Upcoming dividend of JP¥20.00 per share at 4.1% yield

Third quarter 2023 earnings released: JP¥33.72 loss per share (vs JP¥25.61 profit in 3Q 2022)

Create Medic Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: EPS: JP¥20.54 (vs JP¥19.67 in 2Q 2022)

Upcoming dividend of JP¥17.00 per share at 4.1% yield

Create Medic Co., Ltd. to Report Q2, 2023 Results on Aug 04, 2023

First quarter 2023 earnings released: EPS: JP¥14.18 (vs JP¥14.51 in 1Q 2022)

Create Medic Co., Ltd., Annual General Meeting, Mar 30, 2023

Full year 2022 earnings released: EPS: JP¥50.56 (vs JP¥72.57 in FY 2021)

Create Medic Co., Ltd. Announces Dividend for the Year Ended December 31, 2023, Payable on March 31, 2023 and Provides Dividend Guidance for the Second Quarter and Year End of Fiscal Year Ending December 31, 2023

Now 20% undervalued

Upcoming dividend of JP¥20.00 per share

Create Medic Co., Ltd. to Report Fiscal Year 2022 Results on Feb 13, 2023

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: JP¥25.61 (vs JP¥20.67 in 3Q 2021)

Create Medic Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022

Create Medic Co., Ltd. to Report Q3, 2022 Results on Oct 31, 2022

Second quarter 2022 earnings released: EPS: JP¥19.67 (vs JP¥29.91 in 2Q 2021)

Create Medic Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022

Upcoming dividend of JP¥17.00 per share

Create Medic Co., Ltd. to Report Q2, 2022 Results on Aug 04, 2022

First quarter 2022 earnings released: EPS: JP¥14.51 (vs JP¥14.95 in 1Q 2021)

Less than half of directors are independent

Create Medic Co., Ltd. to Report Q1, 2022 Results on May 06, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Create Medic Co., Ltd. Provides Consolidated Earnings Guidance for the Second Quarter Ending June 2022 and Full Year Ending December 31, 2022

Upcoming dividend of JP¥20.00 per share

Third quarter 2021 earnings released: EPS JP¥20.67 (vs JP¥14.28 in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥29.91 (vs JP¥25.87 in 2Q 2020)

Upcoming dividend of JP¥17.00 per share

Create Medic Co., Ltd. Provides Dividend Guidance for the Full Year Ending December 2021, 2021

First quarter 2021 earnings released: EPS JP¥14.95 (vs JP¥0.75 in 1Q 2020)

Full year 2020 earnings released: EPS JP¥71.13 (vs JP¥77.83 in FY 2019)

Create Medic Co., Ltd. to Report Q1, 2021 Results on May 06, 2021

Full year 2020 earnings released: EPS JP¥71.13 (vs JP¥77.83 in FY 2019)

Create Medic Co., Ltd., Annual General Meeting, Mar 30, 2021

Upcoming Dividend of JP¥20.00 Per Share

Create Medic Co., Ltd. to Report Fiscal Year 2020 Results on Feb 10, 2021

New 90-day low: JP¥958

Create Medic Co., Ltd. to Report Q3, 2020 Results on Oct 29, 2020

CEO

테뉴어

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령